BILLERICA, Massachusetts – Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Optimal Industrial Automation and Technologies, a leader in pharma and biopharma process analytical technology (PAT), pharma manufacturing automation and Quality Assurance (QA) software and systems integration, based in the United Kingdom. The Optimal biopharma tools acquisition strengthens Bruker as a key software and solutions provider for small […]
La Rioja, SPAIN – Estación Enológica de Haro (EEH), a public and governmental laboratory situated in the major wine growing region La Rioja, Spain, announces its new wine analysis service for public and private organizations in the oenological sector. The first of its kind to be provided by a laboratory in Spain, the service uses Bruker’s […]
PERTH, Australia – Bruker today announces another significant milestone in its collaborator’s efforts to map the long-term risk of disease related to SARS-CoV-2 infection using nuclear magnetic resonance (NMR) spectroscopy. Researchers from the Australian National Phenome Center (ANPC) have recently published results from a study that demonstrate the use of NMR to measure the increased cardiovascular risk […]
Toronto, CANADA — ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced that Pharmaron Inc. has chosen to equip their scientists with ACD/Labs’ industry leading NMR processing and interpretation software. Among the applications adopted by Pharmaron is ACD/Structure Elucidator Suite, bringing computer assisted structure elucidation into their analytical services […]
CALGARY, AB – Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) (“Nanalysis” or the “Company”) announces that the Company has received repayable funding of $4,985,000 to expand manufacturing operations and global markets for nuclear magnetic resonance products from the government of Canada. “We are very thankful for the support from the Canadian government,” said Sean Krakiwsky, founder and Chief Executive […]
PRINCETON, N.J. — NJ Bio is procuring an 800 MHz NMR spectrometer with a cryogenic probe from JEOL. As part of this collaboration, NJ Bio will contribute its expertise in antibody drug conjugates, oligonucleotide conjugates, and other chemistries to develop platform solutions for its drug discovery clients – in particular, a platform for using NMR-derived […]
New Olive Oil Analysis Solution also for Fourier 80™ Cryogen-Free Benchtop FT-NMR ETTLINGEN, Germany – Bruker today launches a new NMR Olive Oil-Profiling 1.0™ solution for authenticity verification and quality control of olive oil, which is one of the most adulterated food products worldwide. This further expands Bruker’s food analysis solutions portfolio and will be […]
PRINCETON, N.J. — NJ Bio is procuring an 800 MHz NMR spectrometer with a cryogenic probe from JEOL. As part of this collaboration, NJ Bio will contribute its expertise in antibody drug conjugates, oligonucleotide conjugates, and other chemistries to develop platform solutions for its drug discovery clients – in particular, a platform for using NMR-derived […]
Peabody, MA – JEOL USA is proud to announce the next generation of JEOL NMR spectrometers: the ECZ Luminous series. This product is a next step in spectrometer miniaturization and improving performance through state-of-the-art digital and high-frequency technologies. JEOL USA is a subsidiary of JEOL ltd, a well-respected manufacturer of cutting-edge scientific equipment with more than […]
BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) today announces new capabilities for its benchtop Fourier transform (FT) nuclear magnetic resonance (NMR) spectrometer, the Fourier 80, which does not require special lab infrastructure or cryogens, and offers excellent 1H sensitivity of 200:1 for gradient spectroscopy proton probes. A new adjustable temperature option increases experimental flexibility, while new […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
